Skip to main content

Year: 2022

Rental home in apartment building most sustainable housing form – Survey on renters’ views on sustainable housing

SATO CorporationPress release 16 December 2022 at 10:00 am Renting a home in an apartment building is perceived as the most sustainable housing form according to responses to a survey commissioned by SATO. The central location of a home enables a more sustainable lifestyle. A total of 55% of the respondents hope to receive guidance from the rental housing provider in issues relating to sustainable housing. According to a survey commissioned in November by housing investment company SATO, a rental home in an apartment building is the most sustainable form of housing. Conducted through an online panel, the survey had 1,005 respondents who live in a rental home or are considering moving into a rental home within the next 12 months. One in four respondents regard a rental home in an apartment building as the most sustainable form of housing....

Continue reading

AWILCO DRILLING PLC – AWDR: Key information relating to reverse split and change of ISIN

Name of company: Awilco Drilling PLC Name of issuer of Sponsored Norwegian Depository Receipts (“SNDRs”): Nordic Issuer Services AS Date on which the corporate action was made public: 23 November 2022 Reverse split ratio: 100 old SNDRs give 1 new SNDR (100:1) Last day including right: 19 December 2022 Ex-date: 20 December 2022 Record date: 21 December 2022 Date of approval: 8 December 2022 Previous ISIN: NO0012740218 New ISIN: NO0012785098 First day trading on new ISIN: 20 December 2022 Other information: The number of SNDRs received by each holder of SNDRs, other than Awilhelmsen Offshore AS, will be rounded up to the nearest whole number of SNDRs. The number of SNDRs received by Awilhelmsen Offshore AS will be rounded down correspondingly.

Continue reading

Contrat de financement avec European High Growth Opportunities Securitization Fund

Contrat de financement avec European High Growth Opportunities Securitization Fund Rappel du contexte NEOLIFE (Euronext Growth Paris – Code ISIN FR0011636083 – Mnémonique ALNLF) (la « Société ») a signé le 1er juillet 2022 un contrat de financement (le « Contrat de Financement ») avec le fonds d’investissement luxembourgeois European High Growth Opportunities Securitization Fund (l’« Investisseur »). Cette ligne de financement flexible sur 18 mois, par émission de 400 bons d’émission d’obligations convertibles ou échangeables en actions nouvelles et/ou existantes de la Société d’une valeur nominale de 5.000 euros chacune (les « OCEANE »), se décompose en 8 tranches d’un montant nominal maximum de 250.000 euros, correspondant à l’émission d’un nombre maximum de 50 OCEANE chacune. Le montant nominal maximum total des OCEANE ainsi émises...

Continue reading

Tempo Provides Third Quarter 2022 Financial and Operational Results Commentary and 2022 and 2023 Guidance

SAN FRANCISCO, Dec. 15, 2022 (GLOBE NEWSWIRE) — Tempo Automation Holdings, Inc. (Nasdaq: TMPO, “Tempo”, or the “Company”), a leading software-accelerated electronics manufacturer, is providing commentary on its previously issued financial results for the three and nine-month periods ended September 30, 2022 and 2021 and is updating its guidance for anticipated annual 2022 and 2023 results. Third Quarter 2022 and Recent Operational Highlights  • The Company (formerly known as ACE Convergence Acquisition Corp.) completed its business combination with Tempo Automation, Inc., resulting in Tempo becoming a publicly traded company. The combined company now operates under the name “Tempo Automation Holdings, Inc.” and its common stock and warrants are listed on the Nasdaq Stock Market under the ticker symbols “TMPO” and “TMPOW”, respectively.  • The...

Continue reading

Proactive news headlines including Kinetiko Energy, Noxopharm, Australian Strategic Materials and Aurumin Ltd

Sydney, Dec. 16, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Kinetiko Energy Ltd (ASX:KKO) has received firm funding commitments from a private South African institution to raise A$2.95 million (before costs) through the exercise of an option. Click here Noxopharm Ltd (ASX:NOX) has lauded the award of a $1.5 million grant to the Hudson Institute of Medical Research – the company’s strategic partner – from the National Health and Medical Research Council (NHMRC) Ideas Grant Scheme. Click here Australian Strategic Materials Ltd (ASX:ASM) has signed a non-binding business agreement with the Chungcheongbuk Province in Korea and the Vietnam Rare Earth Company (VTRE). Click here Aurumin Ltd (ASX:AUN) has entered into...

Continue reading

CGG Announces the Sale of its US Land Seismic Multi-Client Library

Paris, France – December 16, 2022 CGG announced today the sale, to Bon Ton Seismic LLC (Bon Ton), of its US land seismic multi-client library encompassing approximately 20,000 square miles (about 52 000 km2) of 3D seismic data for a total cash consideration of US$63 million. Commenting on the transaction, Sophie Zurquiyah, CEO of CGG, said: “The sale of our US Land data library is part of a continuous process of business portfolio management that was initiated in 2018.  Earth Data will continue to focus on key prolific offshore hydrocarbon basins, CCUS, Minerals & Mining, and Digital. We are pleased to put our extensive land portfolio in the capable hands of Bon Ton.” About CGG CGG (www.cgg.com) is a global technology and HPC leader that provides data, products, services and solutions in Earth science, data science, sensing and monitoring....

Continue reading

Investor calendar 2023

In 2023 AS Merko Ehitus will publish its consolidated financial results according to the schedule below:  Date Event  9 February 2023   2022 12 months and 4th quarter unaudited interim report   6 April 2023   Audited Annual Report 2022  5 May 2023   2023 3 months unaudited interim report  3 August 2023   2023 6 months and 2nd quarter unaudited interim report  2 November 2023   2023 9 months and 3rd quarter unaudited interim report    The annual general meeting of shareholders for approval of 2022 annual report will take place in the second quarter of 2023. Exact time and location will be notified accordingly. Urmas SomelarHead of FinanceAS Merko Ehitus+372 650 1250urmas.somelar@merko.ee AS Merko Ehitus (group.merko.ee) group companies...

Continue reading

Capital increase by issuing shares for utilisation of warrants

The Group CEO and 6 employees have chosen to utilise warrants issued in 2018, cf. company announcement no. 21 of 21 December 2018. Thus, a capital increase of DKK 680,000 is carried out, corresponding to 68,000 shares of DKK 10, and the company’s new share capital will hereafter constitute DKK 94,602,770. The shares are issued at price 48.70, as it appears from the warrant agreement from 2018, and DKK 3,311,60 has there been paid to the company. Best regards,FirstFarms A/S For further information:Please visit our website www.firstfarms.com or contact CEO Anders H. Nørgaard on telephone +45 75 86 87 87. About FirstFarms:FirstFarms is a Danish stock exchange listed company. We operate FirstFarms with responsibility for the surrounding communities, and we deliver highest quality which is primarily sold locally. We act on new opportunities,...

Continue reading

With 9.0% CAGR, Brain Tumor Drugs Market Size worth USD 4.43 Billion by 2029

According to Fortune Business Insights, the global Brain Tumor Drugs Market size is projected to reach USD 4.43 billion in 2029, at CAGR of 9.0% during forecast period; Rising Cases of Brain Cancer to Progress Market Development Pune, India, Dec. 16, 2022 (GLOBE NEWSWIRE) — The brain tumor drugs market size was valued at USD 2.31 billion in 2021 and USD 2.43 billion in 2022. The market is expected to reach USD 4.43 billion by 2029 with a CAGR of 9.0% during the forecast period. Prevalence of smoking, stress, aging, and electromagnetic radiation is projected to drive market growth. Increasing cases of brain cancer are expected to propel the market course. Presence of strong key players in the market is projected to assist in market development. Fortune Business Insights™ shares this information in its report titled “Brain...

Continue reading

With 14.9% CAGR, Healthcare Supply Chain Management Market Size to Surpass Around USD 6.90 Billion by 2029

According to Fortune Business Insights, Healthcare Supply Chain Management Market to Reach USD 6.90 Billion by 2029 at CAGR of 14.9% during forecast period 2022-2029; Growing Adoption of Cloud-based Solutions to Surge Market Development Pune, India, Dec. 16, 2022 (GLOBE NEWSWIRE) — The global healthcare supply chain management market size was valued at USD 2.29 billion in 2021 and USD 2.61 billion in 2022. The market is expected to reach USD 6.90 billion by 2029 with a CAGR of 14.9% during the forecast period. The growing adoption of Radio Frequency Identification (RFID) has improved supply chain operations and is predicted to boost the demand for healthcare supply chain management. Increasing adoption of cloud-based solutions is set to drive market growth. Initiatives taken by various organizations to make their supply chain operations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.